Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARVEDILOL vs CASPOFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARVEDILOL vs CASPOFUNGIN: Safety Overview

Metric CARVEDILOL CASPOFUNGIN
Total FAERS Reports 13,678 3,814
Deaths Reported 2,246 1,419
Death Rate 16.4% 37.2%
Hospitalizations 6,005 1,638
Average Patient Age 63.9 yrs 47.5 yrs
% Female Patients 45.9% 42.8%
FDA Approval Date Dec 22, 2009 Dec 30, 2016
Manufacturer NorthStar RxLLC Sandoz Inc
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued